Epileptic Encephalopathies with Myoclonic Seizures in Infants and Children (Severe Myoclonic Epilepsy and Myoclonic-Astatic Epilepsy)
Authors:
- Renzo GuerriniRGRenzo Guerrini
- Jean AicardiJAJean Aicardi
- 1 November 2003
- journal article
- review article
- Published by Wolters Kluwer Health in Journal Of Clinical Neurophysiology
- Vol. 20 (6) , 449-461
Abstract
Myoclonic attacks are not characteristic of a specific syndrome. In infancy and early childhood, they are often observed in the context of syndromes that are associated with other types of seizures and with cognitive impairment but no obvious brain lesion. Characterization of the associated seizures and age of expression allows inclusion of a number of cases in two main subgroups: severe myoclonic epilepsy (SME, or Dravet syndrome) and myoclonic-astatic epilepsy (MAE). Severe myoclonic epilepsy is an epileptic encephalopathy with invariably poor outcome in which myoclonic seizures, though frequently observed, may be absent altogether in some children. Prolonged and repeated febrile and afebrile convulsive seizures starting in infancy are the main feature and are probably causally related to cognitive decline. One third of children harbor mutation of the SCN1A gene, but the genetics of SME is probably more complex than expected with simple monogenic disorders. Treatment is usually disappointing. Myoclonic-astatic epilepsy is perhaps more a conceptual category of idiopathic myoclonic epilepsy than a discrete syndrome. Childhood-onset myoclonic-astatic attacks are the characteristic seizures associated in most with episodes of nonconvulsive status and generalized tonic-clonic seizures. Outcome is unpredictable. Either remission within a few years with normal cognition or long-lasting intractability with cognitive impairment is possible. Likewise, the effectiveness of antiepileptic drugs is variable. A number of cases of myoclonic epilepsies in infancy and early childhood, however, remain unclassified, and intermediate forms between the different syndromes exist. They must be distinguished from other syndromes with frequent brief attacks and repeated falls, especially the Lennox-Gastaut syndrome. This differentiation is often difficult and may require extensive neurophysiologic studies.Keywords
This publication has 56 references indexed in Scilit:
- Identification of Epilepsy Genes in Human and MouseAnnual Review of Genetics, 2001
- Myoclonic–astatic epilepsy of early childhood – clinical and EEG analysis of myoclonic–astatic seizures, and discussions on the nosology of the syndromeBrain and Development, 2001
- Severe myoclonic epilepsy in infants – a review based on the Tokyo Women's Medical University series of 84 casesBrain and Development, 2001
- IntroductionEpilepsia, 2001
- De Novo Mutations in the Sodium-Channel Gene SCN1A Cause Severe Myoclonic Epilepsy of InfancyThe American Journal of Human Genetics, 2001
- Severe Idiopathic Generalized Epilepsy of Infancy with Generalized Tonic-Clonic SeizuresNeuropediatrics, 1998
- Early diagnosis of severe myoclonic epilepsy in infancyBrain and Development, 1992
- Bromide treatment of pharmaco-resistant epilepsies with generalized tonic-clonic seizures: A clinical studyBrain and Development, 1992
- Epidemiology of Severe Myoclonic Epilepsy of InfancyEpilepsia, 1990
- Bromides were effective in intractable epilepsy with generalized tonic-clonic seizures and onset in early childhoodBrain and Development, 1988